Birth Control Skin Patch Resulting to Clot Risk, warns FDA
Wearing a birth control skin patch by the women of America is a common incident, but if you lend your hear to the latest caution of the U.S. Food and Drug Administration, it is highly dangerous, since it does carry a risk of serious blood clots that has been found to be higher than the risk already recognized for the birth control pill. While having a talk with the concerned officials of the U.S. Food and Drug Administration it has been found that the latest warning is based on the results of a new study that was able to identify the menace of the augmenting crisis, and the agency has also affirmed that by now it has approved modifications to the labeling for the Ortho Evra Contraceptive Transdermal Patch, for the necessity of warning women and their doctors of the potential risk. Speaking on this Dr. Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs at the FDA, said in a statement, "For women that choose to use contraceptives, it is important that they thoroughly discuss with their health-care providers the risks and benefits involved." It should be noted that the warning has been issued following the recent incidents of two deaths, one heart attack and 16 cases of blood clots since 2004 among women who used the patch, only in Canada on the very last week.
The very birth control skin patch was approved for the first time by the FDA, in the year 2001, and is sold by the means of prescription with the release of ethinyl estradiol (a type of estrogen), and a progestin called norelgestromin via the skin into the bloodstream. However, with the development of time the FDA noted that the body processes hormones were delivering in this way, in a different manner than hormones delivered in pill form, so that "women using the product will be exposed to about 60 percent more estrogen than if they were using typical birth control pills."
IN THE NEWS